Efficacy and safety of dupilumab in antihistamine-refractory, omalizumab-naïve chronic spontaneous urticaria: A systematic review

JAAD Reviews · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles